Medicon Valley Alliance and Metabolon are pleased to invite you to a Good Morning Meeting on the 20th of April in Copenhagen, focusing on advancing basic, clinical and applied research using state-of-the-art metabolomics data. Global biochemical profiling provides an informative assessment of the metabolome, which is reflective of a system’s active biology. Through metabolomics, opportunities are expanded for disease elucidation, biomarker identification, mechanism of action, patient stratification, and more. This session will provide an overview of Metabolon’s unsurpassed metabolomics capabilities and, with case studies, will convey the importance of incorporating such a data stream into a vast array of research application areas including oncology, inflammatory diseases, metabolic disease, infectious disease, neurological disease, skincare, and the microbiome.
Topics will include:
• Metabolomics technology and capabilities
• How to employ metabolomics to achieve your research goals such as disease elucidation, biomarker identification, mechanism of action, patient stratification, and more
• Mapping genetic variants and responses to therapy
• Discovery applications for complex diseases
• Case studies which illustrate the value added from a metabolomics data stream
Date: Thursday 20th of April 2023
Time: 8:30 – 11:00
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Auditorium
PROGRAM
| 8:30 | Networking, registration and light breakfast |
| 9:00 | Welcome David Munis Zepernick, Director, Member Engagement and Communication, Medicon Valley Alliance |
| 9:05 | Metabolon Introduction Brian Kepler, Discovery & Translational Sciences Director, Metabolon |
| Accelerating Life Science Research Through Metabolomics Brian Kepler, Discovery & Translational Sciences Director, Metabolon |
|
| Metabolomics applications to human health Greg Michelotti, Director of International Population Health, Metabolon |
|
| 10:30 | Networking |
| 11:00 | End of Good Morning Meeting |
Speakers
 |
Brian Kepler, Ph.D. Director, Discovery and Translational Sciences, Metabolon, IncDr.Brian Keppler is the Director of Metabolon’s Commercial Discovery and Translational Sciences team and serves as the lead scientific liaison for global business opportunities with pharmaceutical, biotechnology and applied markets companies. Brian has been with Metabolon since 2011 and manages company efforts toward illuminating novel biological insights and supporting meaningful decision-making to accelerate research and development and advance client success. He received his Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill and completed his postdoctoral training at the National Institute of Environmental Health Sciences in Research Triangle Park, NC. |
|
 |
Greg Michelotti, Ph.D. Director of International Population Health, Metabolon, Inc. Greg Michelotti, Ph.D., is the Director of International Population Health at Metabolon, Inc., the global leader in metabolomics that offers the world’s largest metabolomics knowledge base. Dr. Michelotti earned his doctoral degree in biochemistry from the University of South Carolina and applied this training to elucidate the molecular mechanisms under underpinning multi-organ stress response pathways. Since joining Metabolon, Dr. Michelotti leads biology efforts to identify metabolic signatures of disease in large human population cohorts to accelerate our understanding of the metabolic basis of human health and the transition to pathologic states. Before joining Metabolon, Dr. Michelotti led a translational research laboratory at Duke University incorporating a multi-omics approach to understand the molecular basis of liver disease and NASH progression. Collectively, his work has generated over 85 primary, peer-reviewed research publications, resulting in an h-index of 37. |
|
In collaboration with | |
 |
 |